We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current GFOR market cap is 181.68M. The company's latest EPS is USD -3.7898 and P/E is -0.13.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.68M | -16.78M | -12.76M | -7.62M | -7.46M |
| Net Income | -1.83M | -47.9M | -33.61M | -5.38M | -16.09M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -2.51M | -2.74M | -33.08M |
| Net Income | -991k | 4.55M | -82.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 63.61M | 25.2M | 16.48M | 16.32M | 15.65M |
| Total Liabilities | 9.35M | 65.84M | 75.17M | 71.37M | 85.37M |
| Total Equity | -8.54M | -40.64M | -58.69M | -55.06M | -69.72M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 174.19M | 174.37M | 16.48M |
| Total Liabilities | 13.47M | 5.37M | 75.17M |
| Total Equity | -10.9M | -4.17M | -58.69M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -1.06M | -15.01M | -21.95M | -4.03M | -10.03M |
| Investing | 113.35M | -30k | -48k | 35k | 20k |
| Financing | -112.88M | 23.96M | 22.16M | 4.01M | 10.07M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.53M | -1.57M | -21.95M |
| Investing | -171.62M | 569k | -48k |
| Financing | 174.86M | -85k | 22.16M |
| Market Cap | 181.68M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 400 |
| Price to Book Ratio | -0.18 |
| Dividend Yield | - |
| Shares Outstanding | 21.89M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.6 (7.01%) |
| Company Name | Graf Acquisition Corp IV |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://nkgenbiotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
